Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of an exon 27-skipping antisense oligonucleotide as a targeted therapy for refractory skin ulcers in Werner syndrome.

Molecular therapy. Nucleic acids·2026
Same author

Discovery of a Novel Compound Enhancing SVZ Neurogenic Effects via Human Neural Stem Cell-Based Phenotypic Screening.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Comparative EEG analysis of the effects of ketamine enantiomers and metabolites in rhesus macaques.

Journal of neurophysiology·2026
Same author

Disrupted rest-task shift of multi-band electroencephalography complexity in patients with schizophrenia.

Schizophrenia (Heidelberg, Germany)·2025
Same author

Comparative study of ERP habituation to tones and fearful vocalizations in autism spectrum disorders: a translational biomarker for sensory hypersensitivity.

Molecular psychiatry·2025
Same author

Advanced High-Content Phenotypic Screening to Identify Drugs That Ameliorate the Inhibition of Skeletal Muscle Cell Differentiation Induced by Cancer Cachexia Serum.

Pharmaceuticals (Basel, Switzerland)·2025

Related Experiment Video

Updated: May 18, 2026

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
08:34

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis

Published on: June 3, 2016

Screening for adiponectin secretion regulators.

Kyosuke Hino1, Hidetaka Nagata

  • 1Genomic Science Laboratories, Dainippon Sumitomo Pharma Co. Ltd., Konohana-Ku, Osaka, Japan. kyosuke-hino@ds-pharma.co.jp

Vitamins and Hormones
|September 29, 2012
PubMed
Summary
This summary is machine-generated.

New drugs targeting adiponectin (a protein that can help prevent metabolic syndromes) have been identified. These novel regulators bypass the peroxisome proliferator-activated receptor-γ (PPARγ) pathway, potentially avoiding unwanted side effects.

More Related Videos

Isolation, Expansion, and Adipogenic Induction of CD34+CD31+ Endothelial Cells from Human Omental and Subcutaneous Adipose Tissue
10:28

Isolation, Expansion, and Adipogenic Induction of CD34+CD31+ Endothelial Cells from Human Omental and Subcutaneous Adipose Tissue

Published on: July 17, 2018

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function
09:20

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function

Published on: May 4, 2021

Related Experiment Videos

Last Updated: May 18, 2026

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
08:34

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis

Published on: June 3, 2016

Isolation, Expansion, and Adipogenic Induction of CD34+CD31+ Endothelial Cells from Human Omental and Subcutaneous Adipose Tissue
10:28

Isolation, Expansion, and Adipogenic Induction of CD34+CD31+ Endothelial Cells from Human Omental and Subcutaneous Adipose Tissue

Published on: July 17, 2018

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function
09:20

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function

Published on: May 4, 2021

Area of Science:

  • Metabolic syndrome research
  • Adipokine signaling pathways
  • Drug discovery and development

Background:

  • Adiponectin, an adipokine, is crucial for suppressing metabolic syndromes like type 2 diabetes, obesity, and atherosclerosis.
  • Upregulating adiponectin offers therapeutic benefits, making it a significant drug target.
  • Existing adiponectin regulators include cytokines and transcription factors, but many drugs act via peroxisome proliferator-activated receptor-γ (PPARγ), raising concerns about side effects.

Purpose of the Study:

  • To identify novel regulators of adiponectin secretion.
  • To discover drug candidates that act independently of the PPARγ pathway.
  • To explore new therapeutic strategies for metabolic syndromes by targeting adiponectin.

Main Methods:

  • High-throughput screening was employed to identify potential drug candidates.
  • The study focused on identifying regulators that do not rely on PPARγ activation.
  • Investigated various classes of adiponectin regulators, including cytokines and transcription factors.

Main Results:

  • Novel regulators of adiponectin secretion were identified through high-throughput screening.
  • These identified regulators function through a mechanism independent of PPARγ.
  • This discovery opens avenues for drug candidates with potentially fewer PPARγ-related side effects.

Conclusions:

  • PPARγ-independent adiponectin secretion regulators represent promising drug candidates.
  • The identified compounds offer a novel mechanism of action for treating metabolic syndromes.
  • Targeting adiponectin through PPARγ-independent pathways may provide a safer therapeutic approach.